Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Ethnic differences in response to epidermal growth factor receptor tyrosine kinase inhibitors.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 10 May 2006

Calvo Emiliano, Baselga José

Abstract excerpt

The identification of somatic mutations in the tyrosine kinase domain of the epidermal growth factor receptor (EGFR) in non-small-cell lung cancer (NSCLC) and their correlation with response to EGFR inhibitors has become an important event in the fields of cancer genetics and therapeutics. The initial observation of a higher response to gefitinib and erlotinib in patients of Asian origin was followed by the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Carcinoma, Non-Small-Cell Lung

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to ErbB Receptors

Share to Gene Amplification

Share to Genes, erbB-2

Share to Genes, ras

Share to Protein Kinase Inhibitors

Share to Racial Groups

Source

Identifiers

PMID: 16682734
DOI: 10.1200/JCO.2006.06.5961

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Ethnic differences in response to epidermal growth factor receptor tyrosine kinase inhibitors.PMID 16682734Read ↗

Cancer pharmacoethnicity: ethnic differences in susceptibility to the effects of chemotherapy.Semantic proximity Read ↗

Ethnic differences in drug metabolism and toxicity from chemotherapy.Semantic proximity Read ↗

Emerging ethnic differences in lung cancer therapySemantic proximity Read ↗

Genomic profiles specific to patient ethnicity in lung adenocarcinoma.Semantic proximity Read ↗

Interethnic difference in the allelic distribution of human epidermal growth factor receptor intron 1 polymorphism.Semantic proximity Read ↗

Population-based differences in treatment outcome following anticancer drug therapies.Semantic proximity Read ↗

Ethnicity affects EGFR and KRAS gene alterations of lung adenocarcinomaSemantic proximity Read ↗

Additional impact of genetic ancestry over race/ethnicity to prevalence of KRAS mutations and allele-specific subtypes in non-small cell lung cancer.Semantic proximity Read ↗

Geographic Variation in EGFR Mutation Frequency in Lung Adenocarcinoma May Be Explained by Interethnic Genetic Variation.Semantic proximity Read ↗

Ethnic differences in idiopathic pulmonary fibrosis: The Japanese perspective.Semantic proximity Read ↗

Variability in organ-specific EGFR mutational spectra in tumour epithelium and stroma may be the biological basis for differential responses to tyrosine kinase inhibitorsSemantic proximity Read ↗

Ethnic variation in the thymidylate synthase enhancer region polymorphism among Caucasian and Asian populations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.